Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study

BACKGROUND: There is limited information regarding the optimal third-line therapy for managing type 2 diabetes mellitus (T2DM) that is inadequately controlled using dual combination therapy. This study assessed the efficacy and safety of pioglitazone or glimepiride when added to metformin plus alogl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Metab J
Main Authors: Kim, Jeong Mi, Kim, Sang Soo, Kim, Jong Ho, Kim, Mi Kyung, Kim, Tae Nyun, Lee, Soon Hee, Lee, Chang Won, Park, Ja Young, Kim, Eun Sook, Lee, Kwang Jae, Choi, Young Sik, Kim, Duk Kyu, Kim, In Joo
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Diabetes Association 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7043969/
https://ncbi.nlm.nih.gov/pubmed/31339011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2018.0274
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados